These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

828 related items for PubMed ID: 23466968

  • 21. Importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban.
    Gong IY, Kim RB.
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S24-33. PubMed ID: 23790595
    [Abstract] [Full Text] [Related]

  • 22. New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation.
    Aguilar MI, Kuo RS, Freeman WD.
    Neurol Clin; 2013 Aug; 31(3):659-75. PubMed ID: 23896498
    [Abstract] [Full Text] [Related]

  • 23. [Differential therapy with the new anticoagulants, 5].
    Stiefelhagen P.
    MMW Fortschr Med; 2013 May 16; 155(9):20. PubMed ID: 23951642
    [No Abstract] [Full Text] [Related]

  • 24. Novel oral anticoagulants: efficacy, laboratory measurement, and approaches to emergent reversal.
    Gehrie E, Tormey C.
    Arch Pathol Lab Med; 2015 May 16; 139(5):687-92. PubMed ID: 25927153
    [Abstract] [Full Text] [Related]

  • 25. Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.
    Bauer KA.
    Stroke; 2013 Jun 16; 44(6 Suppl 1):S38-40. PubMed ID: 23709725
    [No Abstract] [Full Text] [Related]

  • 26. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era.
    Contractor T, Levin V, Martinez MW, Marchlinski FE.
    Postgrad Med; 2013 Jan 16; 125(1):34-44. PubMed ID: 23391669
    [Abstract] [Full Text] [Related]

  • 27. [New anticoagulants: dabigatran, rivaroxaban and apixaban].
    Vargas Ruiz AG, Ramírez López AN, Medina Viramontes ME.
    Gac Med Mex; 2012 Jan 16; 148(3):257-64. PubMed ID: 22820359
    [Abstract] [Full Text] [Related]

  • 28. Anticoagulation: a GP primer on the new oral anticoagulants.
    Brieger D.
    Aust Fam Physician; 2014 May 16; 43(5):254-9. PubMed ID: 24791763
    [Abstract] [Full Text] [Related]

  • 29. Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.
    Miller CS, Grandi SM, Shimony A, Filion KB, Eisenberg MJ.
    Am J Cardiol; 2012 Aug 01; 110(3):453-60. PubMed ID: 22537354
    [Abstract] [Full Text] [Related]

  • 30. Oral anticoagulation in atrial fibrillation: balancing the risk of stroke with the risk of bleed.
    Kosar L, Jin M, Kamrul R, Schuster B.
    Can Fam Physician; 2012 Aug 01; 58(8):850-8. PubMed ID: 22893338
    [No Abstract] [Full Text] [Related]

  • 31. A review of oral anticoagulants in patients with atrial fibrillation.
    Greenspon AJ.
    Postgrad Med; 2012 Nov 01; 124(6):7-16. PubMed ID: 23322134
    [Abstract] [Full Text] [Related]

  • 32. Novel oral anticoagulants for VTE prevention in orthopedic surgery: overview of phase 3 trials.
    Friedman RJ.
    Orthopedics; 2011 Oct 01; 34(10):795-804. PubMed ID: 21956181
    [Abstract] [Full Text] [Related]

  • 33. Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.
    Chan KE, Edelman ER, Wenger JB, Thadhani RI, Maddux FW.
    Circulation; 2015 Mar 17; 131(11):972-9. PubMed ID: 25595139
    [Abstract] [Full Text] [Related]

  • 34. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
    Dumont B, Faille D, Ajzenberg N.
    Med Sci (Paris); 2011 May 17; 27(5):493-500. PubMed ID: 21609670
    [Abstract] [Full Text] [Related]

  • 35. Approach to the new oral anticoagulants in family practice: part 1: comparing the options.
    Douketis J, Bell AD, Eikelboom J, Liew A.
    Can Fam Physician; 2014 Nov 17; 60(11):989-95. PubMed ID: 25392438
    [Abstract] [Full Text] [Related]

  • 36. {blacktriangledown} Apixaban and {blacktriangledown} rivaroxaban for stroke prevention in AF.
    Drug Ther Bull; 2014 Jan 17; 52(1):6-9. PubMed ID: 24401533
    [Abstract] [Full Text] [Related]

  • 37. Direct thrombin and factor Xa inhibition for stroke prevention in patients with atrial fibrillation.
    Galanis T, Merli GJ.
    Hosp Pract (1995); 2013 Feb 17; 41(1):26-36. PubMed ID: 23466965
    [Abstract] [Full Text] [Related]

  • 38. [New oral anticoagulants are as safe in elderly patients as conventional drugs].
    Steurer J.
    Praxis (Bern 1994); 2014 Aug 20; 103(17):1032. PubMed ID: 25146949
    [No Abstract] [Full Text] [Related]

  • 39. Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.
    Quinlan DJ, Eriksson BI.
    Best Pract Res Clin Haematol; 2013 Jun 20; 26(2):171-82. PubMed ID: 23953905
    [Abstract] [Full Text] [Related]

  • 40. [Atrial fibrillation: what the GP needs to know].
    Diener HC, Kaeufer T, Bode C.
    MMW Fortschr Med; 2011 Sep 22; 153(38):44-7; quiz 48. PubMed ID: 21977796
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.